EP Patent

EP0409281A1 — (R-(R*R*))-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl-3-phenyl-4((phenylamino)-carbonyl)-1H-pyrrole-1-heptanoic acid, its lactone form and salts thereof

Assigned to Warner Lambert Co LLC · Expires 1991-01-23 · 35y expired

What this patent protects

[R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-((1-­methylethyl)-3-phenyl-4-[(phenylamino)-carbonyl]-1 H -­pyrrole-1-heptanoic acid or (2R-trans)-5-(4-fluorophenyl)-­2-(1-methylethyl-N,4-diphenyl-1-[2-(tetrahydro-4-hydroxy-6-­oxo-2 H -pyran-2-yl)ethyl]-1 H -pyrrole-3-carboxamide;…

USPTO Abstract

[R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-((1-­methylethyl)-3-phenyl-4-[(phenylamino)-carbonyl]-1 H -­pyrrole-1-heptanoic acid or (2R-trans)-5-(4-fluorophenyl)-­2-(1-methylethyl-N,4-diphenyl-1-[2-(tetrahydro-4-hydroxy-6-­oxo-2 H -pyran-2-yl)ethyl]-1 H -pyrrole-3-carboxamide; a process for their preparation and pharmaceutically acceptable salts thereof.

Drugs covered by this patent

Patent Metadata

Patent number
EP0409281A1
Jurisdiction
EP
Classification
—
Expires
1991-01-23
Drug substance claim
No
Drug product claim
No
Assignee
Warner Lambert Co LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.